InFuse Bone Growth Products May Cost Medtronic Inc. More than $120 Million over Alleged Injuries, Pa

Medtronic Inc. indicated that it plans on recording a charge of $120-$140 million to resolve hundreds of lawsuits brought over its InFuse bone growth product. Port Washington, New York (PRWEB) May 16, 2014 Parker Waichman LLP, a national law firm long dedicated to protecting the rights of victims injured by defective medical devices, reports that device maker, Medtronic Inc., announced plans to record a charge of between $120 and $140 million to resolve hundreds of lawsuits brought over its InFuse bone growth product, according to a May 6, 2014 report by the Minneapolis/St. Paul Business J
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories